Abbott has announced that its FreeStyle Libre 3 continuous glucose monitor (CGM) system has now been cleared by the US Food and Drug Administration (FDA). The company claims that the FreeStyle Libre 3 ...

Abbott’s recently FDA-cleared FreeStyle Libre 3 continuous glucose monitor system can be worn for up to two weeks at a time and automatically sends blood sugar readings to a user’s smartphone every ...

Health care technology company Abbott has recalled certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems because the sensors are displaying incorrect glucose ...

Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...

The FreeStyle Libre 3 reader and app are not impacted. Internal testing determined that some of the sensors from among three lots may provide incorrect high glucose readings, which if undetected may ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

"The FreeStyle Libre 3 system is a direct result of listening to our customers — and giving them the innovation and sensing technology they've been looking for," said Jared Watkin, senior vice ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted clearance for a standalone reader to be ...

Abbott Laboratories has issued an urgent medical device correction concerning its FreeStyle Libre 3 sensors. The announcement on the company’s official website highlights a defect in a specific batch ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...